IBM Stock Stabilizes Amid Mainframe Cycle

IBM's stock has taken a hit in recent months, plummeting by 22% over the last quarter. However, this decline is largely attributed to a cyclical downturn in mainframe sales, which make up just 15% of IBM's total revenue.

The tech giant's generative AI consulting business, on the other hand, has seen significant growth, reaching $5.5 billion and showing no signs of slowing down.

While investors have been deterred by IBM's lackluster performance, patient investors can take heart in the company's stable earnings and low valuations.

With shares trading at 17.3 times forward earnings and 31.8% below June's all-time high, IBM's stock presents a compelling buy opportunity for those willing to wait out the mainframe cycle's inevitable upturn.